C J Hackbarth
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Molecular Medicine top 0.5%
- Epidemiology top 5%
- Pharmacology top 1%
- Co-authors
- Henry F. ChambersMerle A. SandeJoaquim TriasMartin G. TäuberRichard WhiteThomas A. DrakeZhengyu YuanMartin Rusňák
- Topics
- Antimicrobial Resistance in Staphylococcus (25 papers)Antibiotics Pharmacokinetics and Efficacy (16 papers)Antibiotic Resistance in Bacteria (13 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
C J Hackbarth
48 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 1.3k
- Molecular Biology 1.0k
- Molecular Medicine 832
- Epidemiology 829
- Pharmacology 778
Countries citing papers authored by C J Hackbarth
This map shows the geographic impact of C J Hackbarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Hackbarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Hackbarth more than expected).
Fields of papers citing papers by C J Hackbarth
This network shows the impact of papers produced by C J Hackbarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Hackbarth. The network helps show where C J Hackbarth may publish in the future.
Co-authorship network of co-authors of C J Hackbarth
This figure shows the co-authorship network connecting the top 25 collaborators of C J Hackbarth. A scholar is included among the top collaborators of C J Hackbarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Hackbarth. C J Hackbarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 17 | |
| 3 | 54 | |
| 4 | 42 | |
| 5 | 26 | |
| 6 | 44 | |
| 7 | 237 | |
| 8 | 23 | |
| 9 | 64 | |
| 10 | 72 | |
| 11 | 162 | |
| 12 | 34 | |
| 13 | 14 | |
| 14 | 32 | |
| 15 | 24 | |
| 16 | 60 | |
| 17 | 9 | |
| 18 | 89 | |
| 19 | 6 | |
| 20 | 12 |
About C J Hackbarth
C J Hackbarth is a scholar working on Molecular Medicine, Microbiology and Infectious Diseases, having authored 48 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (25 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antibiotic Resistance in Bacteria (13 papers). The work is most often cited by research in Molecular Medicine (832 citations), Infectious Diseases (1.3k citations) and Clinical Biochemistry (451 citations). C J Hackbarth has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Henry F. Chambers, Merle A. Sande, Joaquim Trias, Martin G. Täuber, Richard White, Thomas A. Drake, Zhengyu Yuan, Martin Rusňák, Wen Wang and Peter S. Margolis. Their work appears in journals such as Science, Biochemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.